isradipine has been researched along with Hyperplasia in 1 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heider, JG | 1 |
| Weinstein, DB | 1 |
| Pickens, CE | 1 |
| Lan, S | 1 |
| Su, CM | 1 |
1 review available for isradipine and Hyperplasia
| Article | Year |
|---|---|
Anti-atherogenic activity of the calcium channel blocker isradipine (PN-200-110): a novel effect on matrix synthesis independent of calcium channel blockade.
Topics: Animals; Arteries; Arteriosclerosis; Calcium Channel Blockers; Cells, Cultured; Cholesterol, Dietary | 1987 |